Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma

A clinically relevant subset of patients with soft tissue sarcoma presents with either locally advanced or upfront metastatic disease, or will develop distant metastases over time, despite successful treatment of their primary tumour. The currently available systemic agents to treat such advanced ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yannick, Wozniak, Agnieszka, Cornillie, Jasmien, Avilés, Pablo, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267286/
https://www.ncbi.nlm.nih.gov/pubmed/35806460
http://dx.doi.org/10.3390/ijms23137454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267286/
https://www.ncbi.nlm.nih.gov/pubmed/35806460
http://dx.doi.org/10.3390/ijms23137454

Ejemplares similares